William Cefalu, MD
Director of the Division of Diabetes, Endocrinology & Metabolic Diseases, NIDDK/NIH, USA
Dr. William Cefalu is the Director of the Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM) at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH). Prior to joining the NIH in August 2019, Dr. Cefalu served as Chief Scientific, Medical & Mission Officer of the American Diabetes Association (ADA). From 2012 to 2017, Dr. Cefalu was the Executive Director, the George A. Bray, Jr. Endowed Super Chair in Nutrition, and a professor at Louisiana State University’s (LSU) Pennington Biomedical Research Center (Pennington Biomedical) in Baton Rouge, LA.
During his nearly 35-year career as a physician caring for patients, a scientist, and a health care expert, Dr. Cefalu has been an active leader within the endocrine and diabetes scientific and medical communities. As an extramural investigator, Dr. Cefalu had research support from the NIH for more than 25 years and was the principal investigator for two NIH-funded research centers. His clinical and basic science research focused specifically on interventions to improve the metabolic state of individuals with insulin resistance and type 2 diabetes, and in the cellular mechanisms for insulin resistance. In addition, over his career, he has played an active role in scholarly publications. From 2003 to 2011, he served as Associate Editor of Diabetes Care, the ADA’s clinical research and care journal, and Diabetes, the ADA’s basic science journal. From 2011-2017, he served as the editor-in-chief of Diabetes Care, and under his tenure, Diabetes Care achieved the highest impact factor in its history.
Dr. Cefalu earned his BS from Southeastern Louisiana University and his MD from LSU Heath Science Center. He completed his Internal Medicine residency and served as chief resident at the University of California, Irvine, Veterans Affairs Long Beach Healthcare System. He completed a fellowship in Endocrinology at the David Geffen School of Medicine, Center for Health Sciences at the University of California, Los Angeles. In addition to his tenure at the ADA and Pennington Biomedical, he has also held academic appointments at Tulane University School of Medicine, Wake Forest University School of Medicine, and at the University of Vermont College of Medicine. Dr. Cefalu is widely published in journals, books, and book chapters, including more than 300 publications and 25 book chapters, and served as the editor of five books on the management of diabetes.